| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/28/1997 | EP0775197A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor |
| 05/28/1997 | EP0775150A1 Endotoxin reduction or removal process |
| 05/28/1997 | EP0775142A1 Substituted o6 -benzylguanines and 6(4)-benzyloxypyrimidines |
| 05/28/1997 | EP0775140A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 05/28/1997 | EP0775138A1 TETRAHYDROPYRIDINYLMETHYL DERIVATIVES OF PYRROLO 2,3-b]PYRIDINE |
| 05/28/1997 | EP0775135A1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics |
| 05/28/1997 | EP0775132A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 05/28/1997 | EP0775131A2 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects |
| 05/28/1997 | EP0775129A1 3-benzoyl benzofuran derivatives as thyroid hormone antagonists |
| 05/28/1997 | EP0775120A1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 05/28/1997 | EP0775118A1 Benzimidazole derivatives having dopaminergic activity |
| 05/28/1997 | EP0775113A1 N-substituted azabicycloheptane derivatives useful as neuroleptics |
| 05/28/1997 | EP0775103A1 Retinoic acid x-receptor ligands |
| 05/28/1997 | EP0679097B1 Tgf-beta formulation for inducing bone growth |
| 05/28/1997 | EP0667850B1 Tartronic acids, their acetalic ethers and o-esters |
| 05/28/1997 | EP0569380B1 Acridine derivatives |
| 05/28/1997 | CN1150820A Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150803A Pyrazolo and pyrrolopyridines |
| 05/28/1997 | CN1150802A Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 05/28/1997 | CN1150799A Benzoheterocyclic derivatives |
| 05/28/1997 | CN1150758A Process for preparation of acanthoic acid and pharmaceutical composition comprising same |
| 05/28/1997 | CN1150754A Human osteoclast-derived cathepsin |
| 05/28/1997 | CN1150589A New sulfuric acid esters of sugar alcohols |
| 05/28/1997 | CN1150548A Drug for curing leukopenia and radiation damage |
| 05/28/1997 | CN1035006C Method for preparing peptide of effect having bradykinin-antagonistic agent |
| 05/27/1997 | US5633287 N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| 05/27/1997 | US5633280 Urethanes and ureas that induce cytokine production |
| 05/27/1997 | US5633275 Photochemotherapeutical obstruction of newly-formed blood vessels |
| 05/27/1997 | US5633270 Thiazolidine derivatives, preparation thereof and drugs containing samem |
| 05/27/1997 | US5633266 Azacyclic compounds compositions containing them and their use as tachykinin antagonists |
| 05/27/1997 | US5633257 Phosphodiesterase inhibitor |
| 05/27/1997 | US5633238 Method for the treatment of schizophrenia |
| 05/27/1997 | US5633232 Tachykinin antagonist dipeptides |
| 05/27/1997 | US5633228 Prevention and treatment of peripheral neuropathy |
| 05/27/1997 | US5633227 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 05/27/1997 | US5633149 Polynucleotide encoding novel chemokine expressed in inflamed adenoid |
| 05/27/1997 | US5633147 Transforming growth factor αH1 |
| 05/27/1997 | US5633014 Solid, non-porous microspheres of injectable analgesic and adjuvant that decreases the melting point of the analgesic obtained by spraying mixture in melted state to form droplets and rapidly freezing droplets |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/27/1997 | US5632970 Fluoresence detection using texaphyrins |
| 05/27/1997 | CA2131185C Substituted pipecolinic acid derivatives as hiv protease inhibitors |
| 05/27/1997 | CA1339047C Production of erythropoietin |
| 05/24/1997 | CA2190801A1 Leukotriene antagonistic benzoic acid derivatives |
| 05/22/1997 | WO1997018317A1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof |
| 05/22/1997 | WO1997018309A1 E6 binding proteins |
| 05/22/1997 | WO1997018237A1 Chemokine from niddm pancreas |
| 05/22/1997 | WO1997018236A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX |
| 05/22/1997 | WO1997018223A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | WO1997018212A1 Aryl and heteroaryl purine compounds |
| 05/22/1997 | WO1997018208A1 Quinoline derivatives as type iv phosphodiesterase inhibitors |
| 05/22/1997 | WO1997018206A1 Morpholine derivatives and their use as therapeutic agents |
| 05/22/1997 | WO1997018194A1 CYCLIC AND HETEROCYCLIC N-SUBSTITUTED α-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS |
| 05/22/1997 | WO1997018192A1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 05/22/1997 | WO1997018188A1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
| 05/22/1997 | WO1997017992A1 Improved formulation for administration of steroid compounds |
| 05/22/1997 | WO1997017989A1 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 05/22/1997 | WO1997017988A1 Type ix collagen and chimeras |
| 05/22/1997 | WO1997017973A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017967A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 05/22/1997 | WO1997017966A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017965A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017950A1 Shoulder prosthesis |
| 05/22/1997 | WO1997017949A1 Benzamidoxime prodrugs as antipneumocystic agents |
| 05/22/1997 | WO1997017937A2 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
| 05/22/1997 | WO1997017851A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997007135A3 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 05/22/1997 | WO1997005241A3 Methods and compositions for identifying morphogen analogs |
| 05/22/1997 | CA2549534A1 Benzamidoxime prodrugs as antipneumocystic agents |
| 05/22/1997 | CA2237998A1 Chemokine from niddm pancreas |
| 05/22/1997 | CA2237900A1 Type ix collagen and chimeras |
| 05/22/1997 | CA2237783A1 E6 binding proteins |
| 05/22/1997 | CA2237598A1 Excitatory amino acid receptor antagonists |
| 05/22/1997 | CA2237565A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | CA2235126A1 Quinoline derivatives as type iv phosphodiesterase inhibitors |
| 05/21/1997 | EP0774459A1 Sulfonylamino-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicament containing them |
| 05/21/1997 | EP0774458A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent |
| 05/21/1997 | EP0774457A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent |
| 05/21/1997 | EP0774455A1 Excitatory amino acid receptor antagonists |
| 05/21/1997 | EP0774259A1 New use of organic compounds |
| 05/21/1997 | EP0774257A2 Use of piperazine and homopiperazine compounds for the inhibition of cellular adhesion and infiltration |
| 05/21/1997 | EP0774249A2 Topical composition containing specific flavanones |
| 05/21/1997 | EP0774005A1 Surface expression of enzyme in gene directed prodrug therapy |
| 05/21/1997 | EP0774004A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 05/21/1997 | EP0774003A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 05/21/1997 | EP0773998A1 Novel vesicular acetylcholine carrier |
| 05/21/1997 | EP0773994A1 Receptor-ligand assay |
| 05/21/1997 | EP0773959A1 Adrenergic receptor |
| 05/21/1997 | EP0773958A1 PTH OR PTHrP ANTAGONISTS |
| 05/21/1997 | EP0773950A1 Linked peptide nucleic acids |
| 05/21/1997 | EP0773943A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 05/21/1997 | EP0773942A1 4-indole derivatives as serotonin agonists and antagonists |
| 05/21/1997 | EP0773940A1 Process for synthesis of substituted sulphoxides |
| 05/21/1997 | EP0773939A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 05/21/1997 | EP0773926A1 Difluorostatone antiviral agents |
| 05/21/1997 | EP0773795A1 Antifungal-wound healing compositions and methods for preparing and using same |
| 05/21/1997 | EP0684829A4 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof. |
| 05/21/1997 | EP0623138B1 New adenosine derivatives, preparation methods and pharmaceutical compositions containing them |
| 05/21/1997 | CN1150419A Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same |
| 05/21/1997 | CN1150387A Pharmaceutical preparations and medicaments for prevention and treatment of endothelial dysfunction |